V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008932 | 260005883 | 1.76 | null | Palliative (P) | 2014-05-12 | 2014-05-25 | Rituximab | 2 | null | 260028892 | RITUXIMAB |
| 260008933 | 260005883 | 1.6 | 62.5 | Palliative (P) | 2015-01-27 | 2018-07-08 | Rituximab | N | N | 260028892 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260008934 | 260005884 | 1.65 | 115.6 | null | null | 2017-01-31 | CAPECITABINE + OXALIPLATIN | null | null | 260028896 | ESHAP |
| 260008935 | 260005884 | 1.56 | null | Disease modification (D) | 2016-07-27 | 2016-08-26 | IVE-R | 02 | N | 260028896 | RCEOP |
| 260008936 | 260005885 | null | 76 | Adjuvant (A) | 2018-12-26 | 2019-01-16 | CHOP - 21 days | N | N | 260028898 | CARBOPLATIN + ETOPOSIDE |
| 260008937 | 260005885 | 1.62 | null | Palliative (P) | 2016-03-02 | 2016-06-25 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 260028898 | RITUXIMAB |
| 260008938 | 260005885 | null | 91.6 | Palliative (P) | 2015-10-02 | 2015-10-02 | Rituximab | N | N | 260028898 | ESHAP |
| 260008939 | 260005886 | 1.84 | null | null | null | 2015-08-02 | Rituximab | 02 | N | 260028905 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008940 | 260005886 | null | 114.6 | Adjuvant (A) | 2017-07-04 | 2017-07-04 | Chlorambucil | 02 | N | 260028905 | RITUXIMAB |
| 260008941 | 260005887 | 1.62 | 72.9 | Not known (9) | 2015-04-16 | 2015-04-16 | ECX | 2 | N | 260028909 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008942 | 260012087 | 1.69 | 70 | Palliative (P) | 2017-11-16 | 2017-11-16 | Capecitabine + Oxaliplatin 21day | N | N | 260028910 | RITUXIMAB |
| 260008943 | 260012087 | 1.73 | null | Disease modification (D) | 2017-05-28 | 2017-06-04 | ESPAC-4 TRIAL | N | N | 260028910 | TRIAL |
| 260008944 | 260005888 | 1.86 | 87.4 | Curative (C) | 2015-07-02 | 2017-12-28 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260028918 | RITUXIMAB |
| 260008945 | 260005888 | 1.62 | 88.1 | null | null | 2017-01-31 | Rituximab | null | null | 260028918 | RITUXIMAB |
| 260008946 | 260005889 | 1.78 | 90 | Disease modification (D) | 2014-09-22 | 2014-10-15 | Obinutuzumab + CHOP | N | N | 260028920 | FCR |
| 260008947 | 260005889 | 1.61 | 86.9 | Palliative (P) | 2017-03-19 | 2017-03-26 | ICE-R | N | N | 260028920 | RITUXIMAB |
| 260008948 | 260005890 | null | null | null | null | 2018-01-11 | Rituximab (Maintenance) | null | null | 260028922 | TIP |
| 260008949 | 260005890 | null | 51 | null | null | 2017-12-03 | BENDAMUSTINE | null | null | 260028922 | RITUXIMAB |
| 260008950 | 260005891 | 1.61 | 81.7 | Curative (C) | 2017-06-11 | 2017-06-17 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | 260028926 | RITUXIMAB |
| 260008951 | 260005891 | 1.83 | null | Curative (C) | 2015-06-21 | 2015-06-30 | Rituximab (Maintenance) | 02 | N | 260028926 | RITUXIMAB |
| 260008952 | 260005891 | 1.72 | 48.1 | Disease modification (D) | 2014-12-01 | 2014-12-11 | DHAP - R | N | N | 260028926 | CHLORAMBUCIL + RITUXIMAB |
| 260008953 | 260005892 | 1.63 | 55.8 | null | null | 2015-03-30 | CHOP | null | null | 260028932 | RITUXIMAB |
| 260008954 | 260005892 | 1.55 | null | Palliative (P) | 2015-04-21 | 2015-05-03 | Trial Unspecified | 02 | N | 260028932 | TRIAL |
| 260008955 | 260005893 | 1.9 | 50.8 | Curative (C) | 2016-07-07 | 2016-07-11 | Rituximab | 02 | N | 260028936 | BENDAMUSTINE |
| 260008956 | 260005894 | 1.8 | 64 | Curative (C) | 2017-06-15 | 2017-06-30 | Vinblastine | 02 | N | 260028937 | METHOTREXATE INTRATHECAL |
| 260008957 | 260005894 | 1.51 | null | null | 2016-01-18 | 2016-01-27 | Rituximab | N | N | 260028937 | CHLORAMBUCIL |
| 260008958 | 260005895 | 1.68 | 61.3 | Curative (C) | null | 2016-03-30 | R-EPOCH | null | null | 260028939 | GALLIUM TRIAL |
| 260008959 | 260005895 | 0 | 78.6 | null | 2015-12-16 | 2015-12-16 | Rituximab (Maintenance) | 02 | null | 260028939 | RITUXIMAB |
| 260008960 | 260005896 | 1.71 | 69 | Curative (C) | 2018-01-01 | 2018-01-09 | Doxorubicin + Olaratumab | N | N | 260028943 | RITUXIMAB |
| 260008961 | 260005896 | 1.71 | 56 | null | null | 2016-06-19 | Rituximab | null | null | 260028943 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 260008962 | 260005896 | null | 0 | Neo-adjuvant (N) | 2016-06-07 | 2016-06-07 | ACE (germ cell) | N | N | 260028943 | NOT MATCHED |
| 260008963 | 260005896 | null | 81.1 | Curative (C) | 2014-09-09 | 2014-09-13 | Cisplatin + Pemetrexed | N | N | 260028943 | RITUXIMAB |
| 260008964 | 260005897 | 1.88 | 84 | Curative (C) | 2016-11-16 | 2016-11-18 | CHOP | N | N | 260028949 | VINBLASTINE |
| 260008965 | 260005897 | 1.75 | 134 | Unknown (U) | 2014-11-22 | 2014-11-29 | Cisplatin + Etoposide (5 day) | 02 | N | 260028949 | RITUXIMAB |
| 260008966 | 260005898 | 1.83 | 76.7 | Palliative (P) | 2016-04-06 | 2016-04-20 | CVP R + GEMCITABINE | N | Y | 260028953 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008967 | 260005898 | 1.67 | null | Palliative (P) | null | 2016-12-23 | CHOP - 21 days | N | N | 260028953 | RITUXIMAB |
| 260008968 | 260015586 | 1.65 | 67.8 | null | 2014-11-03 | 2014-11-03 | Rituximab | N | N | 260028962 | RITUXIMAB |
| 260008969 | 260015586 | 1.88 | 111.9 | Palliative (P) | 2017-08-15 | 2017-08-20 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 260028962 | NOT MATCHED |
| 260008970 | 260005899 | null | 76.2 | Curative (C) | 2015-05-13 | 2015-05-27 | Rituximab (Maintenance) | Y | N | 260028967 | CISPLATIN + ETOPOSIDE |
| 260008971 | 260005899 | null | 77.7 | Curative (C) | 2017-08-29 | 2017-09-12 | Rituximab | N | N | 260028967 | CHLORAMBUCIL + RITUXIMAB |
| 260008972 | 260005900 | 1.48 | 61.1 | null | 2016-12-31 | 2017-01-22 | Chlorambucil | N | N | 260028970 | CHOP |
| 260008973 | 260005900 | 1.84 | 72 | Disease modification (D) | 2016-01-26 | 2016-01-28 | DABRAFENIB | N | N | 260028970 | RITUXIMAB |
| 260008974 | 260005901 | null | 118 | null | null | 2016-11-07 | Rituximab | null | null | 260028973 | BENDAMUSTINE |
| 260008975 | 260005901 | 1.78 | 58.4 | Curative (C) | null | 2013-04-15 | Rituximab | null | N | 260028973 | GALLIUM TRIAL |
| 260008976 | 260005901 | 1.69 | 86.7 | Curative (C) | 2017-02-12 | 2017-02-13 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | Y | N | 260028973 | PACIFICO TRIAL |
| 260008977 | 260005902 | 1.81 | 67.9 | null | 2013-10-22 | 2013-10-25 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260028981 | IVADO |
| 260008978 | 260005902 | 1.7 | 98 | Curative (C) | null | 2015-10-26 | Rituximab | N | null | 260028981 | CHLORAMBUCIL |
| 260008979 | 260005903 | null | 93 | null | 2016-08-21 | 2016-08-21 | CISPLATIN + IFOSFAMIDE + VINBLASTINE | 02 | N | 260028984 | CARBOPLATIN + ETOPOSIDE |
| 260008980 | 260005904 | 1.84 | null | Palliative (P) | 2013-05-09 | 2013-05-25 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 260028985 | CHLORAMBUCIL + RITUXIMAB |
| 260008981 | 260005904 | 1.75 | 69.1 | Curative (C) | 2017-04-17 | 2017-04-18 | Rituximab | 2 | null | 260028985 | RITUXIMAB |